CIK 0001689375
- Accelerated filer
- Smaller reporting company
- Emerging growth company
Entrada Therapeutics, Inc.
Sign in to watch- Ticker
- TRDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813983399
- Phone
- +1 857-305-1825
- Business address
- ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
- Former names
- CycloPorters, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,200,939
- in 8 filings
Net −$7,200,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 21 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-25 | Dowden Nathan J Chief Operating Officer | Sale | −3,034 | $20.10 | $61K | 53,697 |
| 2022-10-25 | Dowden Nathan J Chief Operating Officer | Sale | −5,414 | $20.97 | $114K | 48,283 |
| 2022-10-25 | Dowden Nathan J Chief Operating Officer | Sale | −900 | $21.85 | $20K | 47,383 |
| 2022-10-25 | Doshi Dipal President and CEO | Sale | −3,055 | $20.01 | $61K | 195,841 |
| 2022-10-25 | Doshi Dipal President and CEO | Sale | −7,506 | $20.76 | $156K | 188,335 |
| 2022-10-25 | Doshi Dipal President and CEO | Sale | −1,500 | $21.50 | $32K | 186,835 |
| 2022-10-24 | Dowden Nathan J Chief Operating Officer | Sale | −1,102 | $18.88 | $21K | 58,033 |
| 2022-10-24 | Dowden Nathan J Chief Operating Officer | Sale | −1,302 | $19.66 | $26K | 56,731 |
| 2022-10-24 | Doshi Dipal President and CEO | Sale | −1,101 | $18.90 | $21K | 200,137 |
| 2022-10-24 | Doshi Dipal President and CEO | Sale | −1,241 | $19.65 | $24K | 198,896 |
| 2022-10-21 | Dowden Nathan J Chief Operating Officer | Sale | −2,771 | $18.29 | $51K | 59,135 |
| 2022-10-21 | Doshi Dipal President and CEO | Sale | −2,786 | $18.28 | $51K | 201,238 |
| 2022-10-20 | Dowden Nathan J Chief Operating Officer | Sale | −905 | $18.07 | $16K | 61,906 |
| 2022-10-20 | Doshi Dipal President and CEO | Sale | −811 | $18.01 | $15K | 204,024 |
| 2022-09-28 | Doshi Dipal President and CEO | Sale | −3,085 | $15.23 | $47K | 204,835 |
| 2022-09-28 | KREHER NERISSA Chief Medical Officer | Option exercise | +3,122 | $2.10 | $7K | 23,838 |
| 2022-09-28 | KREHER NERISSA Chief Medical Officer | Sale | −3,122 | $15.25 | $48K | 20,716 |
| 2022-09-28 | KREHER NERISSA Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −3,122 | 16,032 | ||
| 2022-09-27 | Doshi Dipal President and CEO | Sale | −3,453 | $15.04 | $52K | 208,886 |
| 2022-09-27 | Doshi Dipal President and CEO | Sale | −966 | $15.82 | $15K | 207,920 |
Page 20 of 26 · 517 trades